Cite
HARVARD Citation
Morrone, D. et al. (2021). Low bleeding and stroke rates with minor age-dependent increase confirm the safety and effectiveness of edoxaban in patients with atrial fibrillation across age groups: Two-year results from ETNA-AF. Europace. p. . [Online].